Chengdu Olymvax Biopharmaceuticals Company Description

Chengdu Olymvax Biopharmaceuticals Inc. engages in the research and development, production, and sales of vaccines for human use.

It offers adsorbed tetanus vaccine; Hib conjugate vaccine; Group A streptococcus vaccine; and AC conjugate vaccine.

The company also provides vaccines for haemophilus influenzae type b; group A and C meningococcal; and staphylococcus aureus, which is in Phase 3 clinical trial.

In addition, it engages in technology promotion and application services business; biotechnology, R&D, and consulting.

The company was founded in 2009 and is based in Chengdu, China.

Chengdu Olymvax Biopharmaceuticals Inc.

Country	China
Founded	2009
Industry	Biotechnology
Sector	Healthcare
Employees	470
CEO	Shaowen Fan

Contact Details

Address: No. 99 Tianxin Road Chengdu, 611731 China
Phone	86 28 6936 1111
Website	olymvax.com

Stock Details

Ticker Symbol	688319
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE1000051H8
SIC Code	2834

Key Executives

Name	Position
Shaowen Fan	Chairman of the Board and GM
Yong Tan	Finance Director
Hengjun Ma	Executive Vice General Manager
Wei Wu	Secretary of the Board of Directors